Proto Labs, Inc. (PRLB) Expected to Post Quarterly Sales of $91.75 Million
Brokerages expect Proto Labs, Inc. (NYSE:PRLB) to report $91.75 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Proto Labs’ earnings, with estimates ranging from $91.60 million to $91.89 million. Proto Labs posted sales of $72.35 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 26.8%. The business is expected to announce its next earnings results before the market opens on Thursday, February 8th.
According to Zacks, analysts expect that Proto Labs will report full year sales of $91.75 million for the current fiscal year, with estimates ranging from $338.00 million to $342.20 million. For the next year, analysts forecast that the firm will report sales of $438.39 million per share, with estimates ranging from $438.27 million to $438.50 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Proto Labs.
Proto Labs (NYSE:PRLB) last posted its quarterly earnings data on Thursday, October 26th. The industrial products company reported $0.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The company had revenue of $88.10 million for the quarter, compared to analysts’ expectations of $85.68 million. Proto Labs had a net margin of 14.53% and a return on equity of 11.63%. Proto Labs’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.51 earnings per share.
Proto Labs (NYSE:PRLB) opened at $111.70 on Friday. The firm has a market cap of $2,980.00, a P/E ratio of 63.47, a P/E/G ratio of 2.36 and a beta of 1.07. Proto Labs has a 52-week low of $48.00 and a 52-week high of $111.80.
In other Proto Labs news, VP John B. Tumelty sold 13,556 shares of the company’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $92.07, for a total value of $1,248,100.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Rainer Gawlick sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $102.75, for a total value of $51,375.00. Following the completion of the sale, the director now directly owns 10,925 shares of the company’s stock, valued at approximately $1,122,543.75. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 19,556 shares of company stock worth $1,814,101. 7.78% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Schwab Charles Investment Management Inc. boosted its stake in Proto Labs by 7.1% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 118,709 shares of the industrial products company’s stock worth $12,228,000 after buying an additional 7,826 shares in the last quarter. Louisiana State Employees Retirement System boosted its stake in Proto Labs by 7.0% in the fourth quarter. Louisiana State Employees Retirement System now owns 10,700 shares of the industrial products company’s stock worth $1,102,000 after buying an additional 700 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in Proto Labs by 12.7% in the third quarter. Public Employees Retirement System of Ohio now owns 93,399 shares of the industrial products company’s stock worth $7,500,000 after buying an additional 10,499 shares in the last quarter. California Public Employees Retirement System boosted its stake in Proto Labs by 131.2% in the third quarter. California Public Employees Retirement System now owns 8,785 shares of the industrial products company’s stock worth $705,000 after buying an additional 4,985 shares in the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new stake in Proto Labs in the third quarter worth approximately $238,000.
ILLEGAL ACTIVITY WARNING: This article was posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/01/20/proto-labs-inc-prlb-expected-to-post-quarterly-sales-of-91-75-million.html.
Proto Labs Company Profile
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.